Abstract
A new class of antimicrobials, in the form of small polypeptides, has been recently discovered in host defense systems throughout the animal kingdom [1–3]. For example, magainins (23-residue polypeptide). secreted by the skin of the African clawed frog. and cecropins (31–38 residues) isolated from the humoral immune systems of insects [1,3] kill bacteria by permeabilizing the cytoplasmic membrane, but do not lyse eukaryotic cells [3]. The present understanding is that all these antimicrobials exert their activity directly on the lipid bilayer of the bacterial cellular membrane, rather than interacting with specific proteins in a cell like the conventional antibiotics. Hence, it is believed that bacteria may not develop resistance to these drugs, but the intriguing question that has to be addressed is, if these antimicrobials act on membranes, how do they selectively attack bacteria without harming the host cells?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.